TrialBMC cancer2026

Gemcitabine as maintenance treatment of diffuse pleural mesothelioma: randomized phase II study.

Mohamed Emam Sobeih et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.